Oral Anticoagulation

Pipeline Programs↗

Active Trials↗

Companies Involved↗

Oral Anticoagulation is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

8/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

clinical trials

Completed5 · 38%

Unknown status4 · 31%

Not yet recruiting2 · 15%

Terminated1 · 8%

Recruiting1 · 8%

Clinical Trials

Trial Activity

13 trials

Pill-in-the-POCKET Oral Anticoagulation Strategy After AF Catheter Ablation

Recruiting·SSeoul National University Hospital·N/A·NCT06216769·400 enrolled

DIrect Oral Anticoagulation and Bioprothesis Aortic Valve

Not yet recruiting·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT05687448·1,500 enrolled

Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease

Not yet recruiting·MMarmara University·Phase 3·NCT06925698·110 enrolled

A Trial of Pharmacist Management of Oral Anticoagulation THerapy in the communitY for AF

Completed·—·Phase 4·NCT04907825·14 enrolled

Comparative Study of Oral Anticoagulation in Left Ventricular Thrombi

Completed·TThe Young Investigator Group of Cardiovascular Research·Phase 3·NCT03926780·79 enrolled

Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI

Completed·UUniversity of Florida·Phase 4·NCT04483583·81 enrolled

Oral Anticoagulation in Hemodialysis

Completed·OOnze Lieve Vrouw Hospital·Phase 4·NCT03799822·132 enrolled

Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation

Completed·BBoston Scientific Corporation·N/A·NCT02928497·481 enrolled

Oral Anticoagulation in Haemodialysis Patients

Terminated·UUniversity Hospital, Strasbourg, France·Phase 4·NCT02886962·50 enrolled

Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures

Unknown status·HHospital Universitario La Fe·Phase 4·NCT05292846·200 enrolled

Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation

Unknown status·—·Phase 4·NCT00776633·614 enrolled

Surgical Revascularization Outcomes After Oral Anticoagulation or Antiplatelets

Unknown status·UUnidade Local de Saúde de Coimbra, EPE·Phase 3·NCT03605433·100 enrolled

Randomized Evaluation of D-dimer Guiding dUration of Oral antiCoagulation thErapy

Unknown status·WWuhan Asia Heart Hospital·N/A·NCT03885180·500 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)